Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 25.54 +0.89 (3.61%)
Previous Close $24.65    52 Week High
Open $25.31    52 Week Low
Day High $25.92    P/E N/A 
Day Low $25.05    EPS
Volume 2,010,958